Wet Lab Experiments
The experimental framework of Project POSEIDON formed the foundation of our biological validation process. This phase aimed to construct, transform, isolate, and verify the engineered genetic constructs responsible for metal-binding peptide synthesis, enabling the final assembly of the biosorption system. Each step was performed using aseptic techniques and standardized molecular biology protocols. The complete experiment spanned from August 30 to October 4, 2025.
Overview of Experiments
The wet lab experiments were structured into distinct phases covering reagent preparation, buffer optimization, competent cell preparation, transformation, plasmid extraction, restriction digestion, and verification. The following table provides a chronological overview of the performed experiments.
| Date | Experiment Title | Key Activity | Observation/Outcome |
|---|---|---|---|
| 30 Aug 2025 | Plasmid Procurement | Obtained pET-M10, pET-28b, pTWIST-Amp from Dr. Vinay Bulusu’s lab | Confirmed integrity and labeling of plasmids. |
| 31 Aug 2025 | Media Preparation | Prepared LB broth and LB agar plates | No contamination observed post 24 hr incubation. |
| 01 Sep 2025 | Preparation of Inoue Transformation Buffer (ITB) | Prepared sterile MnCl₂, CaCl₂, KCl, KOH, and PIPES solution | Stored at 4°C post-filtration. |
| 03 Sep 2025 | Competent Cell Preparation | Generated 15 × 50 µL aliquots of chemically competent E. coli (Inoue Method) | Aliquots snap-frozen in liquid nitrogen and stored at −80°C. |
| 05 Sep 2025 | Transformation | pET-M10 transformed into E. coli DH5α and BL21(DE3) | Colonies obtained on Kan⁺ plates; efficiency validated. |
| 08 Sep 2025 | Plasmid Isolation | Performed alkaline lysis miniprep; eluted DNA in NFW | Concentration ≈ 201 ng/µL; A260/280 ≈ 2.0. |
| 11 Sep 2025 | Restriction Digestion | Double digested plasmids and inserts using BamHI and HindIII | Visualized ~220 bp MT band on gel; partial faintness observed. |
| 14 Sep 2025 | Transformation of Constructs | Transformed MT-native, MT-engineered, PCS, and AtPCS into pTWIST-Amp | Stable growth and confirmed transformation. |
| 20 Sep 2025 | Retransformation | pET-28b re-transformed into BL21(DE3) for protein expression | Confirmed success after repeated trials. |
| 04 Oct 2025 | Stock Preservation | Prepared glycerol stocks of all successful clones | Stored at −80°C for long-term use. |
Plasmid Handling and Validation
The plasmids used in the study were procured from Dr. Vinay Bulusu’s lab. They included pET-M10, pET-28b, and pTWIST-Amp vectors. Each plasmid was verified through labeling inspection and resuspension in nuclease-free water. The cultures were revived on LB agar plates and monitored for contamination or unexpected growth patterns.
Ensure availability of verified plasmids as cloning backbones for peptide expression.
All plasmids successfully revived; no contamination observed across multiple replicates.
Preparation of Inoue Transformation Buffer (ITB)
The Inoue method provides highly efficient chemical competence by enhancing cell membrane permeability using divalent ions. The ITB was freshly prepared and filtered before use to maintain sterility. The reagents used and their concentrations are listed below.
| Reagent | Concentration | Role in Buffer |
|---|---|---|
| PIPES | 10 mM | pH stabilizer ensuring cell membrane integrity. |
| KCl | 55 mM | Maintains ionic strength for osmotic balance. |
| MnCl₂ | 15 mM | Enhances competency by altering membrane charge. |
| CaCl₂ | 250 mM | Facilitates DNA binding to the bacterial membrane. |
| KOH | Adjust to pH 6.7 | pH regulation for optimal ionic interaction. |
Mn²⁺ and Ca²⁺ ions promote temporary disruption of membrane charge allowing DNA uptake.
Successfully prepared and sterilized buffer stored at 4°C; retained competency-inducing properties.
Preparation of Competent Cells
Competent cells were prepared following the Inoue method. Pre-cultures were grown overnight and subcultured into fresh LB medium until OD₆₀₀ ≈ 0.4–0.5. Cells were harvested at 4°C, gently washed with ice-cold ITB, and resuspended with DMSO for cryoprotection. A total of 15 × 50 µL aliquots were snap-frozen in liquid nitrogen and stored at −80°C.
- Grow 5 mL overnight culture in LB at 37°C, 200 rpm.
- Dilute 1:100 in 50 mL fresh LB and grow until OD₆₀₀ reaches 0.45.
- Chill culture on ice for 10 min.
- Centrifuge at 2500 × g for 10 min at 4°C; discard supernatant.
- Resuspend pellet in 20 mL ice-cold ITB; repeat wash twice.
- Add 1.5 mL DMSO; incubate on ice 5 min.
- Aliquot 50 µL portions; snap-freeze in liquid nitrogen; store at −80°C.
Generate high-efficiency chemically competent cells capable of uptaking large plasmids.
Cells displayed creamy white pellet morphology indicative of healthy growth; competency confirmed via control transformation.
Transformation of Plasmids
The transformation was carried out using 50 µL aliquots of chemically competent E. coli cells. Each plasmid (pET-M10, pET-28b, pTWIST-Amp) was introduced using the standard heat-shock protocol. Post-recovery, cultures were plated on LB agar supplemented with the appropriate antibiotics (Kanamycin 50 µg/mL, Ampicillin 100 µg/mL). Colonies were visible after 16–18 hours of incubation at 37°C.
| Vector | Antibiotic Selection | Host Strain | Transformation Result |
|---|---|---|---|
| pET-M10 | Kanamycin (50 µg/mL) | E. coli BL21(DE3) | Successful transformation; colonies observed. |
| pET-28b | Kanamycin (50 µg/mL) | E. coli DH5α | Required retransformation due to initial low yield. |
| pTWIST-Amp | Ampicillin (100 µg/mL) | E. coli DH5α | Stable transformation; multiple colonies observed. |
Ice incubation for 30 min → 42°C heat shock for 45 s → immediate recovery on ice → SOC outgrowth 45 min at 37°C.
Stable transformants obtained for all vectors; verified through growth on selective plates and glycerol stock preparation.
Plasmid Isolation
Miniprep of plasmid DNA was conducted using the alkaline lysis method. Each sample was eluted with pre-warmed nuclease-free water to ensure maximum yield. DNA concentration was measured using NanoDrop, recording an average of 201 ng/µL with a purity ratio (A260/280) close to 2.0. The following table summarizes the isolated plasmids.
| Sample ID | Plasmid Type | Concentration (ng/µL) | A260/280 Ratio | Remarks |
|---|---|---|---|---|
| P1 | pET-M10 | 189 | 1.98 | Good yield, clear band. |
| P2 | pET-28b | 205 | 2.01 | Optimal recovery. |
| P3 | pTWIST-Amp (MT-native) | 212 | 2.00 | High purity, stable form. |
| P4 | pTWIST-Amp (PCS) | 198 | 1.96 | Consistent quality. |
| P5 | pTWIST-Amp (AtPCS) | 201 | 1.99 | Used for downstream digestion. |
Extract high-purity plasmid DNA suitable for restriction digestion and cloning.
All samples yielded DNA of analytical-grade quality; minor turbidity observed only in P1 sample.
Restriction Digestion and Gel Electrophoresis
Plasmids and inserts were subjected to double digestion using BamHI and HindIII to confirm fragment release. The reaction mixtures were incubated at 37°C for 1 hour and then electrophoresed on 0.8% agarose gel stained with SYBR Safe. Bands corresponding to ~220 bp for metallothionein (MT) and longer PCS fragments were observed. While most plasmids showed clear digestion patterns, faint bands in PCS lanes indicated partial enzyme efficiency.
Extract high-purity plasmid DNA suitable for restriction digestion and cloning.
All samples yielded DNA of analytical-grade quality; minor turbidity observed only in P1 sample.
Transformation of Gene Constructs
Post-verification, four constructs—MT-native, MT-engineered, PCS, and AtPCS—were transformed into pTWIST-Amp vectors for stable expression. Ampicillin selection (100 µg/mL) was used, and all constructs exhibited robust colony formation. Subsequent streak plating confirmed monoclonality, and glycerol stocks were prepared for preservation.
Establish stable constructs expressing metal-binding peptides under controlled conditions.
All four constructs successfully transformed with high efficiency and verified via growth on Amp⁺ plates.
Final Outcomes
All essential plasmids and recombinant constructs were successfully transformed, isolated, and verified. The quality control checks ensured that each plasmid was free of contamination, with confirmed antibiotic resistance markers. These constructs form the basis for expression testing and downstream biosorption analysis. A summary of key outcomes from each experimental stage is given below.
| Stage | Goal | Observation | Final Outcome |
|---|---|---|---|
| Buffer Preparation | Prepare sterile ITB for competence | Buffer remained stable for 7 days | High-efficiency competence achieved. |
| Competent Cell Generation | Produce 15 × 50 µL aliquots | Healthy pellet morphology | Competent stocks stored at −80°C. |
| Transformation | Introduce plasmids into host cells | Colonies on selective plates | Confirmed transformants. |
| Plasmid Isolation | Extract DNA of high purity | A260/280 ≈ 2.0 | Usable DNA for digestion. |
| Restriction Digestion | Validate inserts by gel bands | 220 bp MT band observed | Confirmed successful digestion. |
| Construct Transformation | Insert engineered genes into Amp vector | Stable colonies obtained | Construct verification complete. |
- Repeat digestion using fresh enzymes to enhance clarity of PCS and AtPCS bands.
- Scale up plasmid prep for downstream protein expression and purification.
- Conduct sequencing verification of all constructs before expression trials.
- Implement cryostorage tracking for long-term plasmid retention.